Senior Engineer
MilliporeSigma
Senior Manager
MilliporeSigma
Process Development Scientist
MilliporeSigma
Scientific Collaboration Using Innovative Remote Technologies
- Time:
When COVID-19 started to spread across continents and become a global pandemic, biopharma manufacturers around the world faced two major challenges: (1) enter the race for treatment of the disease by participating in vaccine development and (2) avoid delays in the production of other essential therapeutics. This video webinar presents two case studies from Europe and Latin America that demonstrate how the global teams across the M Lab™ Collaboration Center network used innovative remote technologies to overcome these challenges and meet important production timelines.
You will explore:
• A remote collaboration in Europe where the team remotely supported process development, scale up and scale out of a COVID-19 vaccine candidate.
• A case study in Latin America where the team used remote technologies to show a customer how to concentrate and diafiltrate their antivenom serum production in Peru.
• A virtual experience of how remote technologies are used to promote scientific collaboration.
A live Q&A session followed the presentation, offering you a chance to pose questions to our expert panelist.
Produced with support from:
